Evidence map›Paper›PMID 26853819›Full record

ArticleBiochimie2016

MTHFD1 regulates nuclear de novo thymidylate biosynthesis and genome stability.

Martha S Field, Elena Kamynina, Patrick J Stover

Open access · greenAbstract read
In one paragraph

Article in Biochimie, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Fructose metabolism is unregulated in cancers and placentae.Experimental biology and medicine (Maywood, N.J.) · 2024
    Review
  7. Regulatory mechanisms of one-carbon metabolism enzymes.The Journal of biological chemistry · 2023
    Review
  8. Article
  9. A Common Polymorphism in theJournal of cardiovascular development and disease · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Arsenic trioxide targets MTHFD1 and SUMO-dependent nuclear de novo thymidylate biosynthesis.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  17. Review
  18. Review
  19. Article
  20. The Roles of SUMO in Metabolic Regulation.Advances in experimental medicine and biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Martha S FieldDivision of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA.
Elena KamyninaDivision of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA.
Patrick J StoverDivision of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA; Graduate Field of Biochemistry, Molecular and Cell Biology, Cornell University, Ithaca, NY 14853, USA. Electronic address: pjs13@cornell.edu.
Cornell University · US

Funding

Homeostatic Regulation of Folate MetabolismR37DK058144 · NIDDK · TEXAS A&M AGRILIFE RESEARCH · PI STOVER, PATRICK J · 2012 to 2021
$3.7M
GENE-NUTRIENT INTERACTIONS IN NEURAL TUBE DEFECTSR01HD059120 · NICHD · CORNELL UNIVERSITY · PI STOVER, PATRICK J · 2008 to 2018
$3.4M
Homeostatic Regulation of Folate MetabolismR01DK058144 · NIDDK · CORNELL UNIVERSITY ITHACA · PI STOVER, PATRICK J · 2002 to 2010
$2.9M
NICHD NIH HHS R01 HD059120NIDDK NIH HHS R01 DK058144NIDDK NIH HHS R37 DK058144
6 · The paper itself

Abstract

Disruptions in folate-mediated one-carbon metabolism (FOCM) are associated with risk for several pathologies including developmental anomalies such as neural tube defects and congenital heart defects, diseases of aging including cognitive decline, neurodegeneration and epithelial cancers, and hematopoietic disorders including megaloblastic anemia. However, the causal pathways and mechanisms that underlie these pathologies remain unresolved. Because folate-dependent anabolic pathways are tightly interconnected and best described as a metabolic network, the identification of causal pathways and associated mechanisms of pathophysiology remains a major challenge in identifying the contribution of individual pathways to disease phenotypes. Investigations of genetic mouse models and human inborn errors of metabolism enable a more precise dissection of the pathways that constitute the FOCM network and enable elucidation of causal pathways associated with NTDs. In this overview, we summarize recent evidence that the enzyme MTHFD1 plays an essential role in FOCM in humans and in mice, and that it determines the partitioning of folate-activated one carbon units between the folate-dependent de novo thymidylate and homocysteine remethylation pathways through its regulated nuclear localization. We demonstrate that impairments in MTHFD1 activity compromise both homocysteine remethylation and de novo thymidylate biosynthesis, and provide evidence that MTHFD1-associated disruptions in de novo thymidylate biosynthesis lead to genome instability that may underlie folate-associated immunodeficiency and birth defects.

Indexed as

Genomic InstabilityAnimalsCongenital AbnormalitiesFolic AcidHomocysteineHumansImmunologic Deficiency SyndromesMetabolism, Inborn ErrorsMethylenetetrahydrofolate Dehydrogenase (NADP)MiceMinor Histocompatibility AntigensThymidine MonophosphateFolic AcidHomocysteineMethylenetetrahydrofolate Dehydrogenase (NADP)Minor Histocompatibility AntigensMTHFD1 protein, humanThymidine MonophosphateDHFRDNA replicationFolateLaminMTHFD1Multi-enzyme complexSHMTThymidylateTYMS

Identifiers

PMID26853819
PMCPMC4899284
OpenAlexW2259793606

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.